Veradermics (MANE) Director John W. Childs Sells 100,000 Shares

What Happened

• John W. Childs, a director of Veradermics, sold a total of 100,000 shares in open-market transactions on August 12, 2026, generating proceeds of approximately $10,711,700. The sales were reported in three tranches:
  • 15,000 shares sold at a weighted average price of $106.14 — proceeds $1,592,100 (F1: price range $105.77–$106.60).
  • 80,000 shares sold at a weighted average price of $107.23 — proceeds $8,578,400 (F3: price range $107.04–$107.76).
  • 5,000 shares sold at $108.24 — proceeds $541,200.
• These were outright sales (code S) — a disposal of shares, not a purchase or option exercise.

Key Details

• Transaction date: August 12, 2026; Form 4 filed August 14, 2026 (filed within the typical 2-business-day window).
• Aggregate shares sold: 100,000; aggregate proceeds: ~$10.71 million.
• Shares owned after transaction: not specified in the supplied details of this summary (see the filed Form 4 for post-transaction holdings).
• Notable footnotes:
  • F1 and F3 note the reported prices are weighted averages from multiple trades within the listed price ranges; full breakdowns per price are available on request to the company/SEC staff.
  • F2 and F4 indicate some or all of these shares are held by the John W. Childs 2013 Revocable Trust and J.W. Childs Associates (FL), L.P.; Childs is Trustee and may be deemed to hold voting/dispositive power over those securities.
• No 10b5-1 trading plan, gift, option exercise, or tax-withholding notation was indicated in the provided transaction details.

Context

• These were open-market sales by a company director. Sales by insiders can be routine (diversification, estate planning, etc.) and do not by themselves indicate the company’s prospects. For full context on remaining holdings and any trading plans, review the complete Form 4 filing (Accession 0001628280-26-057196) on EDGAR.